Perimeter Medical Imaging AI Announces Conference Call and Webcast to Provide Corporate Update

2 years ago

Live Call/Webcast on Wednesday, February 23, 2022 at 5 pm ET TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc.…

Better Therapeutics Enrolls First Patient in Real World Evidence Study with Colorado Prevention Center Clinical Research

2 years ago

Open-label, randomized, controlled study will evaluate BT-001, a prescription digital therapeutic (PDT) delivering cognitive behavioral therapy to address behavioral root…

SimplePractice Partners with Smartlink Health Solutions to Enable Whole Patient Care in North Carolina

2 years ago

The partnership enables participation in North Carolina’s health information exchange (HIE) for thousands of SimplePractice customer practices serving clients using…

Defence Retains CATO SMS to Advise on Its Phase I Clinical Trial on AccuTOX(TM) for Breast Cancer

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

Interim Report January – December 2021

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)October to DecemberNet sales amounted to MSEK 0 (0)Net…

First Patient Recruited to Promore Pharma’s Clinical Trial Regarding Scarring According to Plan

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 16 February 2022 - Promore Pharma AB, a…

New Agreement Regarding Dosell with the Municipality of Scania.

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that our partner Zafe…

Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years

2 years ago

Long-term agreement includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities…

Invitation to the Presentation of IRLAB’s Year-End Report January – December 2021

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / February 16, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB Therapeutics AB (publ) will publish the year-end report…

Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment

2 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / February 16, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to…